← Back to ORGO

Organogenesis Holdings Inc. - Class A financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 08/05/2025
$44$37$151$101$87$115$130$110
−$96−$53$22−$9.4−$19$12−$17−$2.1
−$0.77−$0.44$0.11−$0.10−$0.17$0.09−$0.13−$0.02
129128131127126134133132

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.